{"id":126710,"date":"2014-04-25T09:45:09","date_gmt":"2014-04-25T13:45:09","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/gen-publishing-introduces-clinical-omics-digital-publication.php"},"modified":"2014-04-25T09:45:09","modified_gmt":"2014-04-25T13:45:09","slug":"gen-publishing-introduces-clinical-omics-digital-publication","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/gen-publishing-introduces-clinical-omics-digital-publication.php","title":{"rendered":"GEN Publishing introduces &#39;Clinical OMICs&#39; digital publication"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    24-Apr-2014  <\/p>\n<p>    Contact: Tamlyn Oliver    <a href=\"mailto:toliver@clinicalomics.com\">toliver@clinicalomics.com<\/a>    914-740-2199    Mary Ann Liebert, Inc.\/Genetic    Engineering News<\/p>\n<p>    New Rochelle, NY, April 24, 2014GEN Publishing recently    introduced Clinical OMICs a    semi-monthly digital publication focusing on the application of    OMICs technologies in clinical settings. These advanced    techniques, such as next-gen sequencing, are beginning to    transform medical care just as they revolutionized basic life    science research over the past decade-and-a-half.  <\/p>\n<p>    \"GEN's editors and reporters have written about the research    use of pharmacogenomics, genomics, metabolomics,    transcriptomics, etc. etc. for years,\" said John Sterling,    editor-in-chief of Genetic Engineering & Biotechnology News    (GEN). \"The rapid advance of OMICs technologies has reached the    point where we are convinced that the time is now for a new    publication that shows how these diagnostic methodologies are    dramatically impacting clinical practice.\"  <\/p>\n<p>    Clinical OMICs is directed at clinical lab directors and    managers, oncologists, infectious disease specialists, and    cardiologists. Intended to serve as a resource for the    development and standardization of best OMICs practices,    Clinical OMICs provides critical information and    insights on the trend toward personalized medicine.  <\/p>\n<p>    The premier issue contains articles on translating OMICs into    cancer biology and medicine, how payers are grappling with    reimbursement issues, a profile of Lawrence Brody, who is    overseeing NHGRI's new division of genomics and society, the    move of next-gen sequencing systems into the clinic, and a case    study of a genomics test for coronary artery disease.    Late-breaking clinical OMICs news, OMICs-related clinical APPS,    and new products are also featured.  <\/p>\n<p>    ###  <\/p>\n<p>    About Clinical OMICs  <\/p>\n<p>    Clinical OMICs is brought to you by GEN Publishing, the    parent company of Genetic Engineering &    Biotechnology News.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-04\/mali-gpi042414.php\/RK=0\/RS=.7Y53WsUmhSYgQP0OWy6ExmJqmI-\" title=\"GEN Publishing introduces &#39;Clinical OMICs&#39; digital publication\">GEN Publishing introduces &#39;Clinical OMICs&#39; digital publication<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 24-Apr-2014 Contact: Tamlyn Oliver <a href=\"mailto:toliver@clinicalomics.com\">toliver@clinicalomics.com<\/a> 914-740-2199 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, April 24, 2014GEN Publishing recently introduced Clinical OMICs a semi-monthly digital publication focusing on the application of OMICs technologies in clinical settings. These advanced techniques, such as next-gen sequencing, are beginning to transform medical care just as they revolutionized basic life science research over the past decade-and-a-half. \"GEN's editors and reporters have written about the research use of pharmacogenomics, genomics, metabolomics, transcriptomics, etc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/gen-publishing-introduces-clinical-omics-digital-publication.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-126710","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/126710"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=126710"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/126710\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=126710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=126710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=126710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}